Dublin, Aug. 27, 2024 (GLOBE NEWSWIRE) -- The "North America Medical Oxygen Market, By Country, Competition, Forecast & Opportunities, 2019-2029F" report has been added to ResearchAndMarkets.com's offering.
North America Medical Oxygen Market was valued at USD 3.66 billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.68% through 2029
The North America Medical Oxygen Market is a critical component of the healthcare industry, providing a lifeline to patients with various respiratory conditions and playing a pivotal role in medical interventions. In this comprehensive market overview, we will delve into the key aspects of the North America Medical Oxygen Market, providing detailed insights into its size, growth drivers, challenges, and competitive landscape. 
Rise in Demand for Portable Oxygen Concentrators
The demand for portable oxygen concentrators (POCs) is on the rise in the North American medical oxygen market, driven by several key factors.
Patients are increasingly seeking oxygen therapy options that allow them to maintain an active and mobile lifestyle. POCs provide the flexibility needed for patients to move around, travel, and engage in daily activities while receiving essential oxygen therapy. This mobility is crucial for improving the quality of life for individuals who require continuous oxygen support.
Advances in POC technology have significantly enhanced the efficiency, portability, and user-friendliness of these devices. Modern POCs are now more lightweight and compact, making them easier to carry. They offer longer battery life, improved oxygen delivery, and quieter operation, which enhances user comfort and convenience. These technological improvements make POCs a preferred choice for many patients.
The trend towards home healthcare, particularly in the wake of the COVID-19 pandemic, has accelerated the demand for POCs. The pandemic highlighted the importance of receiving medical care in the safety and comfort of one's home. POCs enable patients to receive necessary oxygen therapy at home, reducing the need for hospital visits and minimizing exposure to potential infections. This shift towards home-based care is supported by healthcare providers and insurers who recognize the benefits of home healthcare in terms of patient outcomes and cost-efficiency.
Telehealth Integration for Oxygen Therapy Monitoring
The integration of telehealth services for monitoring oxygen therapy has emerged as a significant trend in the North America Medical Oxygen Market, driven by patient convenience, real-time monitoring capabilities, and the lasting impact of the COVID-19 pandemic. Telehealth services allow patients to connect with healthcare providers remotely, making it easier to manage oxygen therapy from the comfort of their homes. This is particularly beneficial for patients with chronic respiratory conditions who would otherwise need frequent in-person visits to adjust and monitor their oxygen therapy. The ability to have virtual consultations reduces the logistical burden on patients, saving time and reducing travel-related stress and expenses.
Telehealth platforms facilitate real-time data collection on patients' oxygen saturation levels and adherence to treatment plans. Through these platforms, healthcare providers can continuously monitor patients' conditions and make timely adjustments to their oxygen therapy. This continuous monitoring is crucial for identifying and addressing potential issues before they escalate, thereby improving patient outcomes. In case of emergencies, healthcare providers can intervene promptly, ensuring that patients receive the necessary care without delay.
The COVID-19 pandemic significantly accelerated the adoption of telehealth across various healthcare sectors, including oxygen therapy. During the pandemic, the need to minimize in-person interactions to reduce the risk of virus transmission made telehealth an essential tool. Both patients and healthcare providers became more accustomed to virtual consultations, recognizing the benefits of remote care. As a result, the integration of telehealth for monitoring oxygen therapy has persisted beyond the pandemic, becoming a standard practice in many healthcare settings.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 132 |
| Forecast Period | 2023 - 2029 |
| Estimated Market Value (USD) in 2023 | $3.66 Billion |
| Forecasted Market Value (USD) by 2029 | $5.65 Billion |
| Compound Annual Growth Rate | 7.6% |
| Regions Covered | North America |
Report Scope:
Key Market Players
- Linde PLC
- Air Products and Chemicals Inc
- Air Liquide SA
- Messer SE & Co KGaA
- Keen Compressed Gas Co
- Atlas Copco AB
- AGL Welding Supply Co., Inc.
North America Medical Oxygen Market, By Form:
- Liquid Oxygen
- Compressed Oxygen
- Oxygen Gas Mixture
North America Medical Oxygen Market, By Delivery Mode:
- Tanks/Pipeline
- Cylinder
- Others
North America Medical Oxygen Market, By Application:
- Therapeutics
- Diagnostics
North America Medical Oxygen Market, By End-User:
- Hospitals & Clinics
- Ambulatory Care Centers
- Homecare
- Others
North America Medical Oxygen Market, By Country:
- United States
- Canada
- Mexico
For more information about this report visit https://www.researchandmarkets.com/r/f9yzdy
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
